We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
In March 2012 the ACMD advised that methoxetamine be subject to a temporary class drug order.
Second quarterly progress report, setting out progress on key areas of the Health Visitor Implementation programme
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The strategic outline case and accompanying value for money addendum
Data processor agreement for the GP patient survey, made between the Department of Health and Ipsos MORI.
Impact assessment (IA 1018) on the introduction of independent prescribing by physiotherapists has potential to improve access to medicines by hard to reach and marginalised groups including the homeless, travellers and offe…
The government response to the House of Commons Health Select Committee inquiry on the government’s Alcohol Strategy
From 1 April 2013 responsibility moves tothe NHS Commissioning Board, Clinical Commissioning Groups and/or local authorities
Letter from Professor Sir Mike Richards, National Cancer Director
For those who are new to the concept of programme budgeting an overview of the methodology has been published.
The European Commission has issued a further revised draft of its guidance on Tolerance
An update has been published on the European Commission's discussion paper on health claims on botanical substances used in foods.
The Association of the British Pharmaceutical Industry and the Department of Health have published a Joint DH/ABPI statement
This report sets out the key issues that arose from discussions and provides information on the Department’s approach to the drafting of the regulations.
This publication sets out what organisations can do to help make the objectives in the mental health strategy for England a reality.
Statement on new regulations that have an impact on businesses and other organisations.
This impact assessment (IA No. 4018) was produced with regard to measuring the impact of consolidating and simplifying the fragmented legislation regulating medicines.
This plan addresses the under-representation of black, Asian and minority ethnic (BAME) people on whole organ and bone marrow registers.
This impact assessment (IA 3085) was produced with regard to measuring the impact of the Government's policy related to removing legislation which dictates location and design of no-smoking signs, whilst maintaining the …
Long Term Conditions Compendium of Information: Third Edition.
This impact assessment (IA 3062) was produced with regard to measuring the impact of the Government's policy related to banning the sale of cigarettes from vending machines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).